Kyntra Bio, Inc. (KYNB)
6.97
-0.05
(-0.71%)
USD |
NASDAQ |
Mar 13, 16:00
7.01
+0.04
(+0.57%)
After-Hours: 20:00
Kyntra Bio EPS Diluted (Quarterly) : 36.71 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gossamer Bio, Inc. | -0.2115 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.15M |
| Revenue (Quarterly) | 1.076M |
| Total Expenses (Quarterly) | 14.22M |
| Enterprise Value | -34.25M |
| Gross Profit Margin (Quarterly) | 87.55% |
| Profit Margin (Quarterly) | -1.22K% |
| Earnings Yield | 564.4% |
| Normalized Earnings Yield | 584.07 |